Integrated BioPharma appoints new CEO
This article was originally published in Scrip
Executive Summary
Integrated BioPharma (US) has appointed Jeffrey Leach to succeed Gerald Kay as chief executive officer and president. Mr Leach also was appointed by the board as a director to fill the vacancy created by the death of Zarko Kraljevic in March 2008. Before joining the company in 2006, Mr Leach was a general partner in The Stone Pine Companies.